Natus Medical Incorporated Company Profile (NASDAQ:BABY)

About Natus Medical Incorporated (NASDAQ:BABY)

Natus Medical Incorporated logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:BABY
  • CUSIP: 63905010
  • Web: www.natus.com
Capitalization:
  • Market Cap: $1.12 billion
  • Outstanding Shares: 32,528,000
Average Prices:
  • 50 Day Moving Avg: $33.93
  • 200 Day Moving Avg: $36.05
  • 52 Week Range: $31.65 - $44.39
P/E:
  • Trailing P/E Ratio: 59.79
  • Foreward P/E Ratio: 17.42
  • P/E Growth: 0.94
Sales & Book Value:
  • Annual Revenue: $445.49 million
  • Price / Sales: 2.52
  • Book Value: $13.11 per share
  • Price / Book: 2.63
Profitability:
  • EBIDTA: $48 million
  • Net Margins: 4.20%
  • Return on Equity: 12.09%
  • Return on Assets: 8.06%
Debt:
  • Debt-to-Equity Ratio: 0.26%
  • Current Ratio: 3.33%
  • Quick Ratio: 2.52%
Misc:
  • Average Volume: 375,481 shs.
  • Beta: 0.96
  • Short Ratio: 6.68
 

Frequently Asked Questions for Natus Medical Incorporated (NASDAQ:BABY)

What is Natus Medical Incorporated's stock symbol?

Natus Medical Incorporated trades on the NASDAQ under the ticker symbol "BABY."

How were Natus Medical Incorporated's earnings last quarter?

Natus Medical Incorporated (NASDAQ:BABY) announced its quarterly earnings data on Wednesday, July, 26th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.33 by $0.01. The firm earned $122.20 million during the quarter, compared to analyst estimates of $121.99 million. Natus Medical Incorporated had a net margin of 4.20% and a return on equity of 12.09%. Natus Medical Incorporated's quarterly revenue was up 27.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.39 earnings per share. View Natus Medical Incorporated's Earnings History.

When will Natus Medical Incorporated make its next earnings announcement?

Natus Medical Incorporated is scheduled to release their next quarterly earnings announcement on Wednesday, October, 18th 2017. View Earnings Estimates for Natus Medical Incorporated.

What guidance has Natus Medical Incorporated issued on next quarter's earnings?

Natus Medical Incorporated updated its FY17 earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $1.70-1.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.70. The company issued revenue guidance of $505-510 million, compared to the consensus revenue estimate of $504.56 million.Natus Medical Incorporated also updated its Q3 guidance to $0.37-0.38 EPS.

Where is Natus Medical Incorporated's stock going? Where will Natus Medical Incorporated's stock price be in 2017?

3 equities research analysts have issued 12 month target prices for Natus Medical Incorporated's shares. Their predictions range from $48.00 to $48.00. On average, they expect Natus Medical Incorporated's stock price to reach $48.00 in the next year. View Analyst Ratings for Natus Medical Incorporated.

Who are some of Natus Medical Incorporated's key competitors?

Who are Natus Medical Incorporated's key executives?

Natus Medical Incorporated's management team includes the folowing people:

  • Robert A. Gunst, Independent Chairman of the Board
  • James B. Hawkins, President, Chief Executive Officer, Director
  • Jonathan A. Kennedy, Chief Financial Officer, Executive Vice President, IR Contact Officer
  • Austin F. Noll III, Vice President and General Manager - Neurology Strategic Business Unit
  • D. Christopher Chung M.D., Vice President - Medical Affairs, Quality & Regulatory
  • Doris E. Engibous, Independent Director
  • Kenneth E. Ludlum, Independent Director
  • William M. Moore Jr., Independent Director
  • Barbara R. Paul M.D., Independent Director

Who owns Natus Medical Incorporated stock?

Natus Medical Incorporated's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.76%), Vanguard Group Inc. (7.20%), Dimensional Fund Advisors LP (4.77%), Daruma Capital Management LLC (4.52%), Bank of New York Mellon Corp (2.99%) and Epoch Investment Partners Inc. (2.87%). Company insiders that own Natus Medical Incorporated stock include Austin Francis Noll III, Dong Chune Christopher Chung, Doris Engibous, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Kenneth M Traverso, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical Incorporated.

Who sold Natus Medical Incorporated stock? Who is selling Natus Medical Incorporated stock?

Natus Medical Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Lyon Street Capital LLC, Ashford Capital Management Inc., Ameriprise Financial Inc., Kennedy Capital Management Inc., Epoch Investment Partners Inc., Voya Investment Management LLC, AHL Partners LLP and Martingale Asset Management L P. Company insiders that have sold Natus Medical Incorporated stock in the last year include Doris Engibous, Jonathan Kennedy, Robert A Gunst and William M Moore. View Insider Buying and Selling for Natus Medical Incorporated.

Who bought Natus Medical Incorporated stock? Who is buying Natus Medical Incorporated stock?

Natus Medical Incorporated's stock was bought by a variety of institutional investors in the last quarter, including Koch Industries Inc., Confluence Investment Management LLC, Daruma Capital Management LLC, Marshall Wace North America L.P., Dimensional Fund Advisors LP, Prudential Financial Inc., Hartford Investment Management Co. and Broadfin Capital LLC. View Insider Buying and Selling for Natus Medical Incorporated.

How do I buy Natus Medical Incorporated stock?

Shares of Natus Medical Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natus Medical Incorporated's stock price today?

One share of Natus Medical Incorporated stock can currently be purchased for approximately $34.50.


MarketBeat Community Rating for Natus Medical Incorporated (NASDAQ BABY)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  98 (Vote Underperform)
Total Votes:  215
MarketBeat's community ratings are surveys of what our community members think about Natus Medical Incorporated and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Natus Medical Incorporated (NASDAQ:BABY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $48.00 (39.13% upside)

Analysts' Ratings History for Natus Medical Incorporated (NASDAQ:BABY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/1/2017Benchmark Co.Reiterated RatingBuy -> Buy$55.00 -> $48.00MediumView Rating Details
2/2/2017Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
12/16/2016Off Wall StreetInitiated CoverageSellN/AView Rating Details
4/21/2016Roth CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for Natus Medical Incorporated (NASDAQ:BABY)
Earnings by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Earnings History by Quarter for Natus Medical Incorporated (NASDAQ BABY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/17/2017$0.41N/AView Earnings Details
7/26/2017Q2 2017$0.33$0.34$121.99 million$122.20 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.33$0.30$122.45 million$124.70 millionViewN/AView Earnings Details
2/1/2017Q416$0.53$0.51$107.58 million$107.70 millionViewListenView Earnings Details
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.38$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Natus Medical Incorporated (NASDAQ:BABY)
2017 EPS Consensus Estimate: $1.80
2018 EPS Consensus Estimate: $2.01
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.32$0.32$0.32
Q2 20171$0.38$0.38$0.38
Q3 20171$0.42$0.42$0.42
Q4 20172$0.68$0.68$0.68
Q1 20181$0.39$0.39$0.39
Q2 20181$0.48$0.48$0.48
Q3 20181$0.49$0.49$0.49
Q4 20181$0.65$0.65$0.65
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Natus Medical Incorporated (NASDAQ:BABY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Natus Medical Incorporated (NASDAQ:BABY)
Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 92.65%
Insider Trades by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Institutional Ownership by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Insider Trades by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2017Robert A GunstDirectorSell4,400$35.17$154,748.00View SEC Filing  
8/14/2017William M MooreDirectorSell3,000$34.10$102,300.00View SEC Filing  
6/15/2017James B HawkinsInsiderBuy4,000$33.98$135,920.00View SEC Filing  
5/31/2017James B. HawkinsInsiderBuy6,000$33.81$202,860.00View SEC Filing  
5/25/2017Doris EngibousDirectorSell5,000$32.68$163,400.00View SEC Filing  
2/9/2017Robert A GunstDirectorSell5,000$36.00$180,000.00View SEC Filing  
12/16/2016James B HawkinsInsiderBuy10,000$35.20$352,000.00View SEC Filing  
10/27/2016James B HawkinsInsiderBuy10,000$38.30$383,000.00View SEC Filing  
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.40View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.18View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.00View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.00View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.00View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.50View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.00View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.76View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.44View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.00View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.54View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.00View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.50View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Natus Medical Incorporated (NASDAQ:BABY)
Latest Headlines for Natus Medical Incorporated (NASDAQ:BABY)
Source:
DateHeadline
americanbankingnews.com logoNatus Medical Incorporated (BABY) Expected to Post Quarterly Sales of $121.86 Million
www.americanbankingnews.com - September 18 at 10:48 AM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 17 at 12:52 AM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Expected to Announce Earnings of $0.38 Per Share
www.americanbankingnews.com - September 16 at 8:34 AM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Director Sells $154,748.00 in Stock
www.americanbankingnews.com - September 15 at 8:03 PM
nasdaq.com logoIntegra Divests Assets to Natus, Paves Way for Codman Buyout - Nasdaq
www.nasdaq.com - September 13 at 5:31 PM
finance.yahoo.com logoIntegra Divests Assets to Natus, Paves Way for Codman Buyout
finance.yahoo.com - September 13 at 5:31 PM
americanbankingnews.com logoBrokers Issue Forecasts for Natus Medical Incorporated's Q4 2018 Earnings (BABY)
www.americanbankingnews.com - September 13 at 2:30 PM
finance.yahoo.com logoNatus Medical, Inc. breached its 50 day moving average in a Bullish Manner : BABY-US : September 12, 2017
finance.yahoo.com - September 12 at 4:33 PM
americanbankingnews.com logoBrokers Issue Forecasts for Natus Medical Incorporated's Q4 2017 Earnings (BABY)
www.americanbankingnews.com - September 12 at 8:00 AM
streetinsider.com logoNatus Medical (BABY) to Acquire Neurosurgery Assets from Integra LifeSciences (IART) for $47.5M - StreetInsider.com
www.streetinsider.com - September 11 at 4:58 PM
seekingalpha.com logoNatus Medical to buy neurosurgery assets from Integra for $47.5M; shares ahead 8%
seekingalpha.com - September 11 at 1:58 PM
americanbankingnews.com logoFinancial Comparison: Natus Medical (BABY) and Alliance HealthCare Services (AIQ)
www.americanbankingnews.com - September 10 at 8:24 PM
americanbankingnews.com logoDanaher Corporation (DHR) & Natus Medical (BABY) Head to Head Review
www.americanbankingnews.com - September 10 at 12:26 PM
americanbankingnews.com logo$121.74 Million in Sales Expected for Natus Medical Incorporated (BABY) This Quarter
www.americanbankingnews.com - August 30 at 1:52 AM
americanbankingnews.com logo$0.38 EPS Expected for Natus Medical Incorporated (BABY) This Quarter
www.americanbankingnews.com - August 28 at 8:08 PM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Cut to "Strong Sell" at BidaskClub
www.americanbankingnews.com - August 27 at 10:30 PM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - August 23 at 12:30 AM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Director William M. Moore Sells 3,000 Shares
www.americanbankingnews.com - August 15 at 8:00 PM
americanbankingnews.com logoNatus Medical Incorporated (NASDAQ:BABY) Expected to Announce Quarterly Sales of $121.74 Million
www.americanbankingnews.com - August 12 at 10:16 AM
finance.yahoo.com logoNatus Medical, Inc. – Value Analysis (NASDAQ:BABY) : August 11, 2017
finance.yahoo.com - August 11 at 9:54 PM
americanbankingnews.com logo Analysts Anticipate Natus Medical Incorporated (NASDAQ:BABY) Will Post Earnings of $0.38 Per Share
www.americanbankingnews.com - August 10 at 2:39 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Natus Medical Inc.
finance.yahoo.com - August 10 at 2:35 AM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 29 at 12:43 AM
americanbankingnews.com logoNatus Medical Incorporated (NASDAQ:BABY) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - July 28 at 7:47 PM
finance.yahoo.com logoNatus Medical, Inc. breached its 50 day moving average in a Bearish Manner : BABY-US : July 28, 2017
finance.yahoo.com - July 28 at 5:39 PM
americanbankingnews.com logoFY2017 EPS Estimates for Natus Medical Incorporated Decreased by William Blair (BABY)
www.americanbankingnews.com - July 28 at 12:40 PM
finance.yahoo.com logoNatus Medical Inc Looks to Turn Things Around
finance.yahoo.com - July 27 at 4:40 PM
finance.yahoo.com logoEdited Transcript of BABY earnings conference call or presentation 26-Jul-17 3:00pm GMT
finance.yahoo.com - July 27 at 2:58 AM
finance.yahoo.com logoNatus Medical Announces Second Quarter 2017 Financial Results
finance.yahoo.com - July 26 at 4:55 PM
finance.yahoo.com logoNatus Medical reports 2Q loss
finance.yahoo.com - July 26 at 4:55 PM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Posts Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - July 26 at 12:30 PM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Releases FY17 Earnings Guidance
www.americanbankingnews.com - July 26 at 11:16 AM
americanbankingnews.com logoNatus Medical Incorporated (NASDAQ:BABY) Issues Q3 Earnings Guidance
www.americanbankingnews.com - July 26 at 11:16 AM
americanbankingnews.com logoZacks: Analysts Expect Natus Medical Incorporated (BABY) Will Post Quarterly Sales of $121.71 Million
www.americanbankingnews.com - July 23 at 10:49 AM
businesswire.com logoRobbins Arroyo LLP Is Investigating the Officers and Directors of Natus Medical Incorporated (BABY) on Behalf of ... - Business Wire (press release)
www.businesswire.com - July 21 at 5:54 PM
finance.yahoo.com logoRobbins Arroyo LLP Is Investigating the Officers and Directors of Natus Medical Incorporated (BABY) on Behalf of Shareholders
finance.yahoo.com - July 21 at 5:54 PM
americanbankingnews.com logoNatus Medical Inc (NASDAQ:BABY) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 14 at 8:02 AM
nasdaq.com logoNotable Thursday Option Activity: BABY, CARB, MA - Nasdaq.com - Nasdaq
www.nasdaq.com - July 13 at 10:15 PM
nasdaq.com logoNatus Medical to Hold 2017 Second Quarter Financial Results Conference Call on July 26th - Nasdaq
www.nasdaq.com - July 13 at 5:10 PM
finance.yahoo.com logoETFs with exposure to Natus Medical, Inc. : July 13, 2017
finance.yahoo.com - July 13 at 5:09 PM
feeds.benzinga.com logoNatus Medical to Hold 2017 Second Quarter Financial Results Conference Call on July 26th
feeds.benzinga.com - July 13 at 12:59 PM
americanbankingnews.com logoNatus Medical Incorporated (NASDAQ:BABY) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 4 at 12:33 AM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - July 1 at 6:57 PM
americanbankingnews.com logo$121.71 Million in Sales Expected for Natus Medical Incorporated (BABY) This Quarter
www.americanbankingnews.com - June 29 at 1:12 PM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Upgraded at Zacks Investment Research
www.americanbankingnews.com - June 27 at 8:58 PM
finance.yahoo.com logoETFs with exposure to Natus Medical, Inc. : June 27, 2017
finance.yahoo.com - June 27 at 3:59 PM
americanbankingnews.com logoNatus Medical Incorporated (BABY) Expected to Announce Earnings of $0.33 Per Share
www.americanbankingnews.com - June 27 at 9:46 AM
finance.yahoo.com logoNatus Medical, Inc. breached its 50 day moving average in a Bullish Manner : BABY-US : June 22, 2017
finance.yahoo.com - June 22 at 11:53 AM
nasdaq.com logoNatus Medical Incorporated (Nasdaq: BABY) to Ring The Nasdaq Stock Market Opening Bell - Nasdaq
www.nasdaq.com - June 21 at 4:45 PM
finance.yahoo.com logoToday's Bell Ringer, June 21, 2107
finance.yahoo.com - June 21 at 4:45 PM

Social

Chart

Natus Medical Incorporated (BABY) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff